ArticleJournal of the National Cancer Center2026

Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases.

Danming He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.